Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 3
2010 3
2011 2
2012 1
2014 3
2015 3
2016 1
2017 3
2018 2
2019 2
2020 4
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
Systems cell biology.
Mast FD, Ratushny AV, Aitchison JD. Mast FD, et al. J Cell Biol. 2014 Sep 15;206(6):695-706. doi: 10.1083/jcb.201405027. J Cell Biol. 2014. PMID: 25225336 Free PMC article. Review.
Signaling dynamics and peroxisomes.
Mast FD, Rachubinski RA, Aitchison JD. Mast FD, et al. Curr Opin Cell Biol. 2015 Aug;35:131-6. doi: 10.1016/j.ceb.2015.05.002. Epub 2015 May 29. Curr Opin Cell Biol. 2015. PMID: 26042681 Free PMC article. Review.
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.
Mast FD, Fridy PC, Ketaren NE, Wang J, Jacobs EY, Olivier JP, Sanyal T, Molloy KR, Schmidt F, Rutkowska M, Weisblum Y, Rich LM, Vanderwall ER, Dambrauskas N, Vigdorovich V, Keegan S, Jiler JB, Stein ME, Olinares PDB, Hatziioannou T, Sather DN, Debley JS, Fenyö D, Sali A, Bieniasz PD, Aitchison JD, Chait BT, Rout MP. Mast FD, et al. bioRxiv. 2021 Apr 10:2021.04.08.438911. doi: 10.1101/2021.04.08.438911. Preprint. bioRxiv. 2021. PMID: 33851164 Free PMC article.
Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection.
Jiang Y, Duffy F, Hadlock J, Raappana A, Styrchak S, Beck I, Mast FD, Miller LR, Chour W, Houck J, Armistead B, Duvvuri VR, Yeung W, Haglund M, Wallner J, Wallick JA, Hardy S, Oldroyd A, Ko D, Gervassi A, Murray KM, Kaplan H, Aitchison JD, Heath JR, Sather DN, Goldman JD, Frenkel L, Harrington WE. Jiang Y, et al. Among authors: mast fd. PLoS One. 2021 Nov 17;16(11):e0259902. doi: 10.1371/journal.pone.0259902. eCollection 2021. PLoS One. 2021. PMID: 34788328 Free PMC article.
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.
Mast FD, Fridy PC, Ketaren NE, Wang J, Jacobs EY, Olivier JP, Sanyal T, Molloy KR, Schmidt F, Rutkowska M, Weisblum Y, Rich LM, Vanderwall ER, Dambrauskas N, Vigdorovich V, Keegan S, Jiler JB, Stein ME, Olinares PDB, Herlands L, Hatziioannou T, Sather DN, Debley JS, Fenyö D, Sali A, Bieniasz PD, Aitchison JD, Chait BT, Rout MP. Mast FD, et al. Elife. 2021 Dec 7;10:e73027. doi: 10.7554/eLife.73027. Elife. 2021. PMID: 34874007 Free PMC article.
31 results